Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Del D Miller

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|January 7, 2005
Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphismDel D Miller, Vicki L Ellingrod, Timothy L Holman, et al.
Psychopharmacology Bulletin|February 8, 2007
Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophreniaVicki L Ellingrod, Jeffrey R Bishop, Jessica Moline, et al.
Schizophrenia Research|November 3, 2007
Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variantsVicki L Ellingrod, Del D Miller, Stephan F Taylor, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|July 18, 2008
Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorderJess G Fiedorowicz, Narasimha M Palagummi, Valerie L Forman-Hoffman, et al.
Journal of Psychosomatic Research|August 2, 2012
Evidence for accelerated vascular aging in bipolar disorderSimrit K Sodhi, Jonathan Linder, Catherine A Chenard, et al.
Current Psychiatry Reviews|June 20, 2012
Systematic Review and Meta-analysis of Pharmacological Interventions for Weight Gain from Antipsychotics and Mood StabilizersJess G Fiedorowicz, Del D Miller, Jeffrey R Bishop, et al.
Pharmacogenetics and Genomics|April 3, 2009
Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescentsChadi A Calarge, Vicki L Ellingrod, Laura Acion, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 29, 2009
A candidate gene study of Tardive dyskinesia in the CATIE schizophrenia trialHuei-Ting Tsai, Stanley N Caroff, Del D Miller, et al.
Pharmacotherapy|September 20, 2011
Factors associated with the prescribing of olanzapine, quetiapine, and risperidone in patients with bipolar and related affective disordersMaithri Prabhakar, William G Haynes, William H Coryell, et al.
Journal of Clinical Pharmacology|January 18, 2008
Sex, race, and smoking impact olanzapine exposureKristin L Bigos, Bruce G Pollock, Kim C Coley, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|January 7, 2005
Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphismDel D Miller, Vicki L Ellingrod, Timothy L Holman, et al.
Psychopharmacology Bulletin|February 8, 2007
Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophreniaVicki L Ellingrod, Jeffrey R Bishop, Jessica Moline, et al.
Schizophrenia Research|November 3, 2007
Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variantsVicki L Ellingrod, Del D Miller, Stephan F Taylor, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|July 18, 2008
Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorderJess G Fiedorowicz, Narasimha M Palagummi, Valerie L Forman-Hoffman, et al.
Journal of Psychosomatic Research|August 2, 2012
Evidence for accelerated vascular aging in bipolar disorderSimrit K Sodhi, Jonathan Linder, Catherine A Chenard, et al.
Current Psychiatry Reviews|June 20, 2012
Systematic Review and Meta-analysis of Pharmacological Interventions for Weight Gain from Antipsychotics and Mood StabilizersJess G Fiedorowicz, Del D Miller, Jeffrey R Bishop, et al.
Pharmacogenetics and Genomics|April 3, 2009
Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescentsChadi A Calarge, Vicki L Ellingrod, Laura Acion, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 29, 2009
A candidate gene study of Tardive dyskinesia in the CATIE schizophrenia trialHuei-Ting Tsai, Stanley N Caroff, Del D Miller, et al.
Pharmacotherapy|September 20, 2011
Factors associated with the prescribing of olanzapine, quetiapine, and risperidone in patients with bipolar and related affective disordersMaithri Prabhakar, William G Haynes, William H Coryell, et al.
Journal of Clinical Pharmacology|January 18, 2008
Sex, race, and smoking impact olanzapine exposureKristin L Bigos, Bruce G Pollock, Kim C Coley, et al.
Pageof 4